During the past decade, Clinical Research Institute of Michigan conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 21 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 21 clinical trials were completed. i.e. 210% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute of Michigan" #1 sponsor was "Shire" with 7 trials, followed by "Allergan" with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Evoke Pharma" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute of Michigan" #1 collaborator was "Galapagos NV" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator, "Crohn's and Colitis Foundation" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute of Michigan" are "Crohn's Disease" (5 trials), "Gastroparesis" (4 trials), "Ulcerative Colitis" (4 trials), "Diabetes Mellitus" (3 trials) and "Diabetic Gastroparesis" (3 trials). Many other conditions were trialed in "Clinical Research Institute of Michigan" in a lesser frequency.

Most popular intervention types in "Clinical Research Institute of Michigan" are "Drug" (28 trials), "Other" (5 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Ontamalimab" (4 trials), "Filgotinib" (3 trials), "Placebo to match filgotinib" (3 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute of Michigan" are 29 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Institute of Michigan". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Clinical Research Institute of Michigan, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute of Michigan, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".